Desktop Site
|
26 Apr 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Watch List
Get Quote
*
Notices
|
S&P
BSE SENSEX
73,730.16
-609.28
-0.82 %
Corporate Announcement
Security Code
524804
Company
AUROBINDO PHARMA LTD.
Exchange Received Time
08/04/2021 11:58:16
Exchange Disseminated Time
08/04/2021 11:58:27
Time Taken
00:00:11
Announcement under Regulation 30 (LODR)-Scheme of Arrangement |
04/08/21 11:58
We refer to our letters dated May 28, 2019 and June 3, 2019 informing about the Scheme of Amalgamation of wholly owned subsidiaries of Aurobindo Pharma Limited viz., APL Healthcare Limited and APL Research Centre Limited and Aurozymes Limited and Curepro Parenterals Limited and Hyacinths Pharma Private Limited and Silicon Life Sciences Private Limited with Aurobindo Pharma Limited and letters dated September 7, 2020 and September 14, 2020 informing about modified Scheme of Amalgamation whereby APL Healthcare Limited, a wholly owned subsidiary of the Company, would be excluded from the aforesaid Scheme.
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform you that the Hon''ble National Company Law Tribunal (NCLT), Hyderabad bench vide its order dated March 30, 2021, has approved the said modified Scheme of Amalgamation.
A certified copy of the NCLT Order along with the Scheme is attached herewith for your reference.
Attachment
<< Back
Recently Viewed